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Key questions
What is already known?
 ► Nationally representative surveys were conducted in 
Cambodia in 2002 and 2011 to derive national but 
not subnational estimates of the point prevalence of 
active tuberculosis (TB).
What are the new findings?
 ► This paper therefore provides the first subnational 
estimates of the point prevalence of active TB across 
Cambodia and the first projections of future point 
prevalence in Cambodia.
What do the new findings imply?
 ► These projections provide evidence that may allow 
healthcare resources to be deployed more efficiently 
across Cambodia over the next decade.
 ► However, a key uncertainty remains, namely the 
degree to which the reduction in age-specific point 
prevalence rates observed between the 2002 and 
2011 surveys can be maintained.
 ► Continued support for the national TB control pro-
gramme is therefore required.
AbsTrACT
Introduction Cambodia is among the 30 highest burden 
of tuberculosis (TB) countries. Active TB prevalence has 
been estimated using nationally representative multistage 
sampling that represents urban, rural and remote parts of 
the country, but the prevalence in non-sampled communes 
remains unknown. This study uses geospatial Bayesian 
statistics to estimate point prevalence across Cambodia, 
and demographic modelling that accounts for secular 
trends in fertility, mortality, urbanisation and prevalence 
rates to project the future burden of active TB.
Methods A Bayesian hierarchical model was developed 
for the 2011 National Tuberculosis Prevalence survey to 
estimate the differential effect of age, sex and geographic 
stratum on active TB prevalence; these estimates were 
then married with high-resolution geographic information 
system layers to project prevalence across Cambodia. 
Future TB projections under alternative scenarios were 
then derived by interfacing these estimates with an 
individual-based demographic model.
results Strong differences in risk by age and sex, 
together with geographically varying population structures, 
yielded the first estimated prevalence map at a 1 km 
scale. The projected number of active TB cases within the 
catchment area of each existing government healthcare 
facility was derived, together with projections to the year 
2030 under three scenarios: no future improvement, 
continual reduction and GDP projection.
Conclusion Synthesis of health and geographic 
data allows likely disease rates to be mapped at a 
high resolution to facilitate resource planning, while 
demographic modelling allows scenarios to be projected, 
demonstrating the need for the acceleration of control 
efforts to achieve a substantive impact on the future 
burden of TB in Cambodia.
InTroduCTIon
Tuberculosis (TB) is a leading infectious 
cause of morbidity and mortality world-
wide, accounting for 10.4 million new cases 
and 1.3 million deaths in 2016.1 The disease 
burden is disproportionately concentrated 
in low-income and middle-income coun-
tries, with over 95% of TB deaths occurring 
in these regions.2 3 In 2016, the number of 
new TB cases was estimated at 10.4 million 
and nearly 40% remained undiagnosed.4 
Limited access to healthcare, high treatment 
cost and the social stigma of TB contribute to 
delayed detection and suboptimal treatment 
uptake.5 6 Poor living conditions and over-
crowding further perpetuate the transmis-
sion of TB, which, in turn, leads to social and 
economic insecurity.7 The financial burden 
of TB—due to the loss of income, and the 
logistics and costs of medical care—is high, 
with typical costs amounting to 58% and 39% 
of individual and household annual income, 
respectively, in low-income and middle-in-
come countries.8 In Cambodia, one of the 
countries with the world’s highest burden of 
TB, although TB services and treatment are 
provided free in public healthcare facilities, 
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other financial costs may amount to over 10% of average 
household income per case.9
Cambodia has an active TB prevalence of 817 (95% CI 
690 to 954) per 100 000 population, estimated during 
the 2011 National Tuberculosis Prevalence (NTP) survey 
of individuals aged 15 years or older conducted by the 
National Center for Tuberculosis and Leprosy Control 
(known by its French acronym, CENAT).10 This estimate 
was based on a multistage sampling design that ensured 
urban, rural and remote areas were represented; however, 
for efficiency, only a fraction of communes within each 
stratum was randomly sampled, so while the national 
prevalence can be estimated, the subnational prevalence 
in other, non-sampled communes remains unknown. 
The Global Tuberculosis Report 20171 highlights the 
possible discrepancies in reporting, access to healthcare, 
and differences in TB diagnosis and treatment, masking 
the magnitude of the problem faced by individual prov-
inces across Cambodia. Active case finding—recognised 
as an important step to early diagnosis and treatment11—
has been found to be feasible and cost-effective in 
Cambodia,12–14 but would benefit from reliable estimates 
of the prevalence of active cases across heterogeneous 
communities, to ensure resources are apportioned effi-
ciently and to facilitate effective planning and evaluation 
of interventions.
To this end, we performed Bayesian evidence synthesis 
to fuse epidemiological and spatial data to identify plau-
sible high burden areas (in terms of point prevalence of 
active TB, ie, the proportion of the population who at an 
instant of time have active TB, and number of active TB 
cases) at a fine spatial resolution (1 km2) across Cambodia. 
We then projected the future spatial prevalence of active 
TB across Cambodia under alternative future scenarios. 
This was made possible with the amalgamation of several 
data sources and methods: imputation of the population 
spatial structure over time, demographic modelling of 
the future population and modelling of risk factors asso-
ciated with active TB in a Bayesian hierarchical frame-
work. The modelling provides estimates of likely disease 
burden in the absence of increased funding for control 
programmes and continued reduction in TB prevalence 
seen in the NTP surveys of 2002 to 2011.15
MeTHods
overview of the methodology
The overall approach is to use data fusion to synthesise 
various data sources—the 2011 NTP survey, projected 
population density plots, birth and death rates, and the 
age profile across Cambodia—to project TB prevalence 
across Cambodia over time. Figure 1 gives an overview 
of the data sources and the major steps of the model-
ling framework described in the sections that follow. 
The modelling framework begins with a Bayesian hier-
archical model (TB-NTP model) that was developed 
for the 2011 NTP survey. This model estimates age, 
sex and stratum (urban/rural: for comparison with the 
previous NTP survey in 2002, remote areas were classi-
fied as rural) effects on the TB prevalence in Cambodia, 
accounting for cluster-level random effects. The 
ensuing subsections detail the methodology adopted 
to construct a Demographic Epidemiological Model 
of Cambodia (DEMOKH), an individual-level model 
that represents the population of Cambodia over space 
and time, which was used to forecast the prevalence of 
active TB to the year 2030. Some additional details of 
the methodology are provided in the online supple-
mentary material 1.
Active tuberculosis point prevalence model (Tb-nTP model)
In the second NTP survey conducted in December 2010 
to September 2011 by CENAT,10 62 survey sites (or spatial 
clusters) were randomly selected across Cambodia with 
population proportionate multistage cluster sampling. 
Of the 40 423 eligible participants (age >15 and resident 
at the survey site for at least 2 weeks), 37 417 (92.6%) 
were recruited.
The TB status of survey participants was recorded in the 
NTP survey as a binary variable indicating if the partic-
ipant had bacteriologically positive pulmonary TB or 
not. Hierarchical logistic regression was conducted that 
accounted for features at the individual level (ie, age, sex 
and rural/urban stratum classification) and cluster level, 
to explain heterogeneity within clusters.
Let  pi  be the probability of active TB infection of an indi-
vidual  i  , where  Yi = 1  if  i has active TB and 0 otherwise. We 
model active TB point prevalence as  Yi ∼ Bernoulli
(
pi
)
  
where
 
log
(
pi
1− pi
)
= β
′
xi + γci .
 
Here,  xi  is a vector of individual-level risk factors of active 
TB infection—including age (in categories or contin-
uous, details as follows), sex and urbanisation level, while 
 γci  is a spatial random effect shared by all individuals in 
the commune  ci  to which  i  belongs.
The model adopted a Bayesian framework16 17 to address 
uncertainty by borrowing strength from other clusters 
in the data. Weakly informative priors were assumed 
for all parameters, namely:  βk ∼ Normal
(
0, 1002
)
  
for each component  k  in the individual risk factors 
vector,  γc ∼ Normal(0,σ2),  for commune  c and 
 σ ∼ Gamma(1, 0.01).  Because very few sampled 
communes border each other, there was insufficient 
information to fit a model with spatial correlations in 
the random effects, which were therefore modelled to be 
conditionally independent of each other. The model is 
fully specified in online supplementary material 1.
The posterior distribution of the parameters was esti-
mated via Markov chain Monte Carlo simulation16 17 
and the inference was implemented in the Just Another 
Gibbs Sampler (JAGS) language18 using the rjags 
package in R.19 In total, two chains with 50 000 itera-
tions each were performed and the convergence of the 
Markov chain Monte Carlo samplers was assessed by the 
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Figure 1 Methodology and data. Overview of the data sources and model framework in the manuscript is presented in 
this flow chart. National Tuberculosis Prevalence Surveys (NTP) for 2011 were made available by the National Center for 
Tuberculosis and Leprosy Control (CENAT) in Cambodia. A summary of the methodology is represented by the model 
framework: (A) TB-NTP model, and (B) demographic epidemiological model of Cambodia (DEMOKH). The projections to the 
year 2030 were modelled under three scenarios: no future improvement (should the prevalence rate be maintained at the 2011 
rates), continual reduction (should the prevalence rate decline at the same rate from 2002 to 2011 and gross domestic product 
(GDP) projections (should the fall in the prevalence rate mirror the projected rises in GDP) as represented in the bottom panel. 
TB, tuberculosis.
Heidelberger-Welch and Geweke diagnostics20 21 and 
inspection of the trace plots.
demographic epidemiological model of Cambodia (deMoKH)
Spatial projections
Gaughan and colleagues22 developed high-resolution 
estimates of the geography of the population using the 
United Nations adjusted population distribution of 
Cambodia over the years 2010, 2015 and 2020, which were 
extracted from the WorldPop Project.23 Data were down-
loaded as raster files and processed in QGIS,24 ArcMap25 
and R19 to be partitioned into 1 km grid squares.
To project the prevalence of active TB across Cambodia 
at the time of the 2011 NTP, a pseudo-population of indi-
viduals was first assigned into each grid randomly based 
on age, sex and strata level of the pseudo-individuals 
using the Gaughan population distribution data, and 
with a Monte Carlo sample of the parameters from the 
posterior distribution of the TB hierarchical model; the 
individual’s risk of active TB was computed. This proce-
dure was repeated 100 times and the mean prevalence 
and total number of individuals with active TB was calcu-
lated and spatially visualised.
Temporal projections
The projections of possible future active TB prevalence 
resulted from a three-stage procedure: in stage 1, we 
imputed the current spatial structure of the population, 
as previously described; in stage 2, we ran a demographic 
model on top of the spatial structure, ageing the existing 
population, depleting it by deaths and replenishing it 
with births; and in stage 3, we applied existing or reduced 
age-specific point prevalence rates, stratified by sex and 
urban/rural strata, to the projected future spatial struc-
ture. The three scenarios for changing point prevalence 
are described later in this section.
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For the demographic model, 5-year age-specific fertility 
rates for the country as a whole over the period 2000 to 
2005 were used as a baseline, obtained from the United 
Nations Statistics Division.26 These were then adjusted 
for each region of the country and both strata (rural and 
urban) within each province, by scaling to match the 
number of (living) children under 1 year old in the year 
2008.27 This fertility rate was then held fixed in the model 
to the year 2030. We observed in initial modelling that 
fertility rates varied across provinces and rural/urban 
strata, due to the mismatch between predicted and actual 
numbers of infants. We therefore adjusted fertility rates 
at the province/stratum level, as follows.
The overall sex ratio at birth was estimated via the 
number of male to female infants aged <1 in 2008 and 
held fixed thereafter, that is, at 105 males to 100 females. 
We denote  bm = 0.511  to be the proportion of births that 
are male.
Letting  ϕa  be the national fertility rate for women aged 
 a  , and  Faput   be the number of women aged  a  in prov-
ince  p  , urban/rural stratum  u  in year  t  , we derived the 
expected number of births in each province, stratum and 
year to be
 
Eput =
∑
a
ϕaFaput.
 
The number of children surviving to age 1 was derived 
by separately calculating the expected number of male 
births
 Bput = Eputbm 
and female births
 Gput = Eput(1− bm). 
These were then aged a year, by which time there were 
 B
1
put = Bput
(
1− µ01(t)
)
  boys and  G
1
put = Gput
(
1− µ00(t)
)
  
girls, and thus  E
1
put = B
1
put + G
1
put   children altogether. The 
ratio of this modelled to the actual number of 1-year-olds, 
 N1put   , in the year  t = 2008 , that is,
 
ρpu =
N1pu,2008
E1pu,2008
,
 
was then set as the ‘correction factor’ for province  p , 
stratum  u , which was used to derive the fertility rate there 
for the projections, that is, the fertility rate for province  p , 
stratum  u , age  a , was set to be
 ϕapu = ϕaρpu. 
Annual, sex-specific, 5-year mortality rates were available 
for the 16-year period from 2000 to 2015 from the Global 
Health Observatory data repository of WHO,28 with those 
aged 85 or more grouped together, and those aged <1 
separated from the under 5 age group. These were also 
available for the country as a whole. The log-mortality 
rates within age groups were extrapolated linearly from 
this period to the year 2030, that is,
 logµa
(
t
)
= ba0 + ba1t + ϵat  
where  µa(t)  is the annual mortality rate for individuals 
aged  a  in year  t  . The mortality rate was assumed constant 
over 5-year intervals of age (with those aged <1 having 
their own mortality group, and those aged >85 aggre-
gated in one age group). The model was fit using least-
squares regression to data from the period 2000–2015 
and extrapolated beyond this. Separate models were fit 
for men and women, but the lack of data on differential 
mortality by rural and urban strata prohibited incorpora-
tion of any such effect.
The estimated and projected proportions of the popu-
lation in both rural/urban strata in each province for 
the years 2010, 2015 and 2020 were extracted from the 
WorldPop Project.22 23 The approximately linear change 
over this time frame was extended to the time window 
2008 to 2030.
Using a yearly time step from 2008 to 2030, we redis-
tributed the population within each region between the 
rural and urban strata to match the estimated propor-
tions (details in online supplementary material 1). We 
then calculated for each region and both strata the 
projected number of births (assigned in a fixed male:fe-
male ratio of 511:489 based on the number of living chil-
dren <1 year in 200827) and the number of deaths in each 
year of age. Because we could not obtain migration rates 
between the regions of Cambodia, we froze individuals’ 
province as per the 2008 census data27 and assigned chil-
dren to their mother’s province and stratum.
TB point prevalence was then imputed up to 2030 under 
three scenarios. In the reduced prevalence scenario, 
the reduction in age-specific point prevalence between 
the 2002 and 2011 nationally representative surveys 
was extrapolated to 2030; in the no future improve-
ment scenario, the 2011 estimates were used for 2030. 
Together, these may constitute lower and upper plausible 
bounds for future prevalence of active TB. A moderate 
prevalence reduction model was also considered where 
gross domestic product (GDP) per capita projections for 
Cambodia29 as a proxy for overall development was used 
to inform the rate of improvement in the prevalence of 
active TB in Cambodia. The three models considered 
were, then:
No future improvement scenario: for this, we used the 
posterior mean age, sex, region and stratum-specific 
prevalence estimated from the 2011 prevalence survey 
and applied it to the population from 2010 to 2030.
Continual reduction scenario: we assumed the reduction 
in TB point prevalence for each age group was linear (in 
the log scale) corresponding to the decline observed over 
the 9 years between the NTP surveys of 2002 to 2011.15 
This was then extrapolated to 2030 for each age group. 
To accommodate uncertainty, we resampled from the 
distribution of the age-specific TB rate reductions and 
compounded it yearly to the projected active TB point 
prevalence for years after 2011. Given that the age-spe-
cific 9-year OR for the reduction seen in the 2002 and 
2011 NTPs is  exp
(
βa
)
  for age group  a  , we assumed the 1 
year reduction to be  exp
(
γa
)
  where
 
γa =
βa
9
.
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For each simulation, we sample the 1-year age-specific 
reduction from the distribution as follows:
 
γa ∼ Normal
βa
9
,
[
SE
(
βa
)
9
]2 .
 
GDP projection scenario: in this model, we assume the 
age-specific TB reduction to be exponentially related 
to per capita GDP growth. Let  θt = GDPt/GDP2002  be the 
per capita GDP relative to 2002 and  θ
′
t = GDPt/GDP2011  
be that relative to 2011. Let also  ra,t   be the reduction in 
age-specific TB point prevalence for age  a  and year  t  , 
relative to 2002 (which has previously been estimated for 
 t = 2011 15), and  r
′
a,t   be that relative to 2011. We assume 
 log ra,t = log ra,2011 log θt/ log θ2011  . The parameter  log ra,2011  
is equated to 
 
βa ∼ Normal
(
βa, SE
(
βa
)2)
 
, which is resa-
mpled similarly to the continual reduction model. Projec-
tions are then made by extrapolating this from the 2011 
rates.
Access to Tb healthcare services
The Cambodia healthcare system has an established 
network of public and private providers, but while the 
private healthcare sector provides 61% of healthcare 
services,30 TB care—including control, prevention and 
treatment—is predominantly provided by the govern-
ment sector. Led by CENAT, the national TB control 
programme was set up to control and treat TB, including 
the introduction and countrywide expansion of directly 
observed therapy short-course (commonly known as 
DOTS) since 1994.31 32 Geographical data of government 
healthcare facility—referral hospitals, health posts and 
health centres—were extracted from United Nations 
Office for the Coordination of Humanitarian Affairs33 34 
and coalesced with the spatial distribution of the active 
TB cases to project the number of cases visiting or in the 
catchment of each healthcare facility.
resulTs
The prevalence of bacteriologically positive TB (or active 
TB) in the 2011 NTP survey varied across age and sex of 
the individual, and stratum level of his/her living envi-
ronment (figure 2). An exposure–response relationship 
was observed between older age and active TB that was 
approximately exponential. Active TB was also markedly 
more prevalent in men (OR 2.08, 95% CI 1.66 to 2.62) 
when compared with women. However, after adjusting 
for age, sex and spatial random effects, the evidence for 
differences in urban and rural areas was marginal, with 
slightly higher empirical rates in rural (OR 1.29, 95% CI 
0.83 to 2.01) and remote regions (OR 1.94, 95% CI 0.73 
to 5.20) than urban areas. As a result, heterogeneities in 
the prevalence across the country may be driven mostly 
by the heterogeneous age and sex profiles in different 
provinces.
The 2008 census population (figure 3) forms the 
basis of DEMOKH. Phnom Penh, the capital, was more 
urbanised than the country as a whole and the urban 
populations were mostly of working ages, while more 
rural provinces have relatively more children. Modelled 
fertility rates were higher in rural than urban areas, 
affecting the projected age profiles of the future popula-
tion across the country. As the population of Cambodia 
ages forward in time, DEMOKH projects the population 
to be older and more urbanised (refer to online supple-
mentary material 1); the latter may act to restrain the 
future TB prevalence, while the former elevates it.
The prevalence of active TB varies spatially across the 
country and over time as depicted in figure 4. Generally, 
urban and younger regions had lower projected active 
TB prevalence. However, under the assumption that 
recent improvements to life expectancy continue into 
the immediate future, the population is projected to age 
noticeably, and as a result, should the age-specific and 
sex-specific rates remain at the level they were in 2011 
(the no future improvement scenario), we project a higher 
active TB prevalence with more cases in all regions. 
In contrast, if the historic declines in TB prevalence 
observed between the 2002 and 2011 NTP surveys were 
to extend to 2030 (the continual reduction model), the rise 
in risk due to ageing would be more than countered by 
the reduction in prevalence due to sustained improve-
ment in TB control. Together, these two scenarios, no 
future improvement and continual reduction, may constitute 
upper and lower plausible bounds for future prevalence 
of active TB. The intermediate third scenario, GDP 
projections, provides a more moderate outlook for active 
TB in the future as mirror projected rises in per capita 
GDP in Cambodia. In figure 5, the projected national 
prevalence and total cases for the three scenarios are 
presented to 2030, illustrating the stark differences in 
disease outcomes that would result from continuing the 
improvements observed between 2002 and 2011 and 
rapid development projected for Cambodia.
The projected number of active TB cases within the 
catchment area of each existing government healthcare 
facility—under the assumption of no new facilities—was 
determined (and is presented in figure 6) to forecast the 
future healthcare needs across the country and which 
areas to prioritise for new healthcare facilities. Under 
the no future improvement scenario, the burden of existing 
healthcare facilities is expected to increase across the 
country, but in particular in cities due to increasing 
urbanisation. In contrast, if age-specific TB prevalence 
continues its decline (the continual reduction scenario), 
existing healthcare facilities should see no further growth 
in the number of patients being treated through to 2030 
(figure 6 and online supplementary material 1).
dIsCussIon
Houben and Dodd35 have estimated that about 9 million 
(~60%) of Cambodia’s population were infected with 
latent TB in 2014. As the population of Cambodia ages 
over the next few decades, the resultingly larger pool of 
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Figure 2 Differences in prevalence of bacteriologically positive tuberculosis (TB) across exposures. Modelled bacteriologically 
positive TB prevalence per 100 000 population estimates are represented in the log base 10 scale and are based on individual-
level data from the 2011 NTP survey. The prevalence of active TB varies across age and sex of the individual, and stratum 
level of his/her living environment. The interpretation of violin plots is like box plots: they display the probability density of the 
prevalence estimates at different values. Points are posterior median prevalence estimates, curves are posterior distributions of 
the parameters truncated to within 95% CI.
older individuals—who are more likely to be infected with 
latent TB and at risk of TB reactivation due to chronic 
medical conditions that weaken their immune system's 
ability to prevent infection36—means that the burden of 
TB is expected to increase even if the current age-spe-
cific prevalence can be maintained. It is therefore imper-
ative that the TB control programme, in which recent 
improvements have resulted in a substantial decrease in 
age-specific prevalence between successive NTP surveys, 
continues to expand, lest the burden of TB grow due to 
these demographic changes. In another modelling study, 
Sharma and colleagues37 also recommend additional 
control efforts to combat the increase in drug-resistant 
TB forecast in four other high-burden TB countries.
There are echoes of Alice and the Red Queen in the 
challenge of eliminating TB as a public health problem 
by 2050—without additional funding and support from 
international communities to lower-income, high-burden 
regions, a business-as-usual approach is insufficient to 
overcome this challenge.38 Improved living environments 
and socioeconomic status have substantially reduced 
the burden of TB, which is fundamentally a disease of 
poverty.38 39 There have been substantial improvements 
in the age-specific prevalence of TB in Cambodia since 
the 2002 NTP survey, but if infection rates persist at 
the lower level seen in the 2011 NTP survey, this study 
projects a growth in the number of cases and overall 
prevalence of active TB due to population growth and 
ageing, with concomitant needs for greater provision of 
healthcare facilities to treat these patients. In contrast, 
if the fall in age-specific prevalence can be continued, 
it is entirely feasible that prevalence rates of active TB 
in Cambodia could be driven to as low as 1 per 1000. 
Continued support of the national TB programme is 
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Figure 3 Population age distribution by province and urbanisation category. The population pyramids by age and sex of the 
24 provinces of Cambodia in 2008 is classified by urbanisation extent (urban, the darker area; or rural, the lighter area).
therefore important to effect this outcome. Cambodia, 
as in many other low-income to middle-income coun-
tries (LMICs), has a funding gap for TB treatment and 
prevention, which was estimated to be US$19 million in 
2017.1 The End TB Strategy’s global targets may only be 
realised through an acceleration of improvements, rather 
than the maintenance of recent improvements, through 
research and development.1
In this paper, evidence was synthesised by fusing health 
and geographic data. This allowed for the mapping of 
likely active TB prevalence at a high resolution across 
heterogeneous environments, which could potentially 
facilitate control efforts and resource planning. We 
projected that Cambodia’s major cities, such as Phnom 
Penh and Battambang, have more cases on aggregate, 
due to their larger populations, but lower prevalence due 
to their relatively young age profiles. After accounting for 
demographics and spatial random effects—which repre-
sent local heterogeneities in TB prevalence—there was 
no evidence that urban and rural areas had different 
risk profiles. This may reflect the widespread access 
to care at government health facilities in both strata, 
with the Community DOTS programme, an initiative 
led by CENAT, providing access to TB care to infected 
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Figure 4 Projected point prevalence and cases of active 
tuberculosis (TB) across Cambodia, 2010–2030. Darker 
regions indicate higher prevalence of active TB. Three 
scenarios were modelled—(1) no future improvement: 
future TB prevalence is projected based on the estimates of 
age specific point prevalence in 2011 assuming no further 
improvement to the TB control programme; (2) continual 
reduction: the reduction in age-specific point prevalence 
between the 2002 and 2011 NTP surveys was extrapolated 
to 2030; and (3) gross domestic product (GDP) projections: 
the reduction in age-specific point prevalence of TB brought 
about by rapid development projected for Cambodia until 
2030. No future improvement and continual reduction may 
constitute lower and upper plausible bounds for future 
prevalence of active TB.
Figure 5 Projected change in cumulative active 
tuberculosis (TB) cases and point prevalence in Cambodia 
from 2010 to 2030. Of the three scenarios presented, no 
future improvement and continual reduction may constitute 
lower and upper plausible bounds for future prevalence 
of active TB in Cambodia; the intermediate third scenario, 
gross domestic product (GDP) projections, is based on the 
assumption that TB point prevalence falls mirror projected 
rises in GDP. The no future improvement scenario assumes 
no further improvement to the TB control programme after 
2011; the future TB prevalence projected are based on the 
estimates of age-specific point prevalence in 2011. The 
continual reduction model accounts for the reduction in 
age-specific point prevalence between the 2002 and 2011 
NTP surveys, which was then extrapolated to 2030. the 
GDP projections model accounts for the rapid development 
Cambodia could experience and the reduction it brings 
about to age-specific point prevalence of TB. The darker 
lines indicate the median values.
individuals far from the major cities to ensure they are 
not left behind. As stakeholders’ opinions were regularly 
sought throughout the study, the projection of the poten-
tial burden at government healthcare facilities could be 
useful when apportioning resources in the future that 
are targeted at ameliorating active TB (such as active 
case finding), and may facilitate programme-based oper-
ational research.40
As in every modelling study, the projections involved 
several assumptions. Because of the long latency period 
and strong effect of age on TB, the model focused 
primarily on demographic changes to project the prob-
able presence of active TB at cross-sections in time given 
the demographics structure, rather than transmission 
dynamics. As a result, the model cannot be used directly 
to assess the impact of specific changes to the control 
programme, and future work, similar to that undertaken 
elsewhere,41–50 would be valuable as Cambodia seeks ways 
to improve its programme further. The model assumes 
that the risk factors determined from the 2011 NTP survey 
can be extrapolated spatially to other regions across 
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Figure 6 Projected catchment size of the government healthcare facility in Cambodia in 2030. The size of the points 
corresponds to the number of active tuberculosis (TB) cases within the catchment area of a government healthcare facility. 
Two scenarios for 2030 are presented, no future improvement (points in black) and continual reduction (points in hues of red). 
The burden of the healthcare facility is expected to change over time, with 2010 in blue vs 2030 in dark grey (for the no future 
improvement scenario) and red (for a continual reduction scenario).
Cambodia and temporally. The former is reasonable, 
given the design of the NTP survey, and we assessed the 
sensitivity of projections to the latter through scenarios 
in which future rates are the same as in 2011 or decline 
either at the same rate as over the period 2002 to 2011 or 
based on projected per capita GDP growth. There were 
stark differences between the no-change and declining 
prevalence scenarios, indicating that a range of outcomes 
are possible, and future NTP surveys could be used to 
refine these projections in due course. These projections 
account for demographic and economic changes but 
not for other biological, social or policy changes that are 
known to influence TB risk, such as the provision of social 
protection programmes,51 52 whose effect is assumed to 
be subsumed within the three scenarios. Although very 
rich geospatial data were used to estimate the current 
and future population distribution across regions of 
Cambodia, little information was available on migration 
rates between different parts of the country. While we 
were able to project future urbanisation, the precise loca-
tions of new or expanded urban conglomerations were 
not available. As a result, there is a risk that the spatial 
projection of cases may deviate from the eventual one. 
The effect of international migration on TB in Cambodia 
is also not accounted for due to the paucity of the data—
Cambodia has a large diaspora and TB rates are known 
to be high among Cambodian migrants in Thailand,53–55 
for example. Future research in this area would be invalu-
able. This work could also enable analyses of disparities 
in healthcare access by contrasting incident case notifica-
tions with the spatial projections of point prevalence of 
active TB, which could help identify areas to focus future 
interventions. Our findings encourage further research 
into health systems’ architecture and optimal resources 
allocation to achieve continual reduction in TB preva-
lence, in the face of other emerging public health chal-
lenges, such as the rise in non-communicable disease that 
accompanies ageing populations, that LMICs encounter 
as they undergo the epidemiological transition.56 This 
paper provides a successful example of data synthesis 
from multiple independent sources to inform health 
system strengthening efforts in LMICs.
As in many other TB high-burden countries, TB case 
finding has traditionally been done passively at health 
centres where patients with active TB symptoms seek 
medical care and the providers are able to diagnose 
the conditions accurately.57 This strategy is, however, 
inadequate to measure the burden of undiagnosed TB 
in the community. In 2016, almost 38% of patients with 
TB remain undiagnosed or not notified despite a 100% 
DOTS strategy coverage nationwide.1 30 Narrowing this 
gap in diagnosis is one way to effect the reduction in the 
future risk of TB needed to see the lowering of the TB 
burden in Cambodia as projected in this modelling study.
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